Touch suppression

Touch suppression is a reduction in tactile sensitivity in which touch feels muted, distant, or difficult to localize.

As a drug effect it is acute and dose-proportional, easing as the substance wears off; it differs from clinical conditions such as peripheral neuropathy in having no pathological basis. It ranges from a mild softening of surface sensation to near-complete numbness in which physical contact registers only faintly.

Touch suppression is commonly reported across several drug classes. It is most often induced at moderate to high doses under dissociatives such as ketamine and dextromethorphan, and under psychedelics such as 25B-NBOMe and 25B-NBOH; it also appears under stimulants such as cocaine and A-PHP, and at higher doses of depressants such as alcohol and GBL.

Touch suppression is felt as a dulling of the body's surface: textures lose their usual character, pressure arrives at a remove, and the boundary between skin and surroundings becomes imprecise. Temperature and pain signals are similarly blunted.

People often notice it first when touching something normally felt sharply — a rough surface, a firm grip — and finding the input strangely flat. Attending to the numbness can make it more pronounced rather than resolving it. At higher doses, particularly under dissociatives, sensation can diminish to the point that the body feels entirely foreign.

Touch suppression arises through different pathways depending on the drug class:

• Dissociatives — block NMDA receptors, disrupting thalamic relay of somatosensory signals and reducing cortical processing of tactile input.
• Psychedelics — act on 5-HT2A receptors, altering sensory gating in ways that can mute rather than amplify tactile signals.
• Stimulants — act partly through peripheral sodium channel blockade; the effect is most established with cocaine, which has well-characterized local anaesthetic properties.
• Depressants — enhance GABAergic inhibition, reducing overall neural excitability and the salience of incoming tactile signals.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses reliably deepen the suppression across all associated classes. Set and setting have less influence here than on perceptual or emotional effects — touch suppression is largely physiological — though anxious attention to the body can make its absence more salient.

People with a higher baseline tactile sensitivity tend to notice it more readily. Prior familiarity with the substance has little protective effect, as the suppression is dose-driven rather than shaped by expectation.